Pfizer third-quarter profit beats estimates; oncology drugs shine

(Reuters) - Pfizer Inc reported better-than-expected third-quarter earnings on Tuesday, helped by costs cuts and growing sales of recently approved cancer medicines.

from Reuters: Business News http://feeds.reuters.com/~r/reuters/businessNews/~3/2o1nqMpO0JQ/story01.htm